Nervgen Pharma Stock Quote NGEN - Stock Price, News, Charts, Message Board, Trades

Professional-Grade Tools, for Individual Investors.

Premium

Current Price

2.86

Bid

2.86

Ask

2.89

Volume

20,651

2.85 Day's Range 2.90

0.00 52 Week Range 0.00

Market Cap

170.473M

Previous Close

2.86

Open

2.86

Last Trade

900

2.86

Last Trade Time

Financial Volume

VWAP

Average Volume (3m)

Shares Outstanding

59,606,000

Dividend Yield

PE Ratio

-7.62

Earnings Per Share (EPS)

-0.38

Revenue

Net Profit

-22.38M

Sector

Pharmaceutical Preparations

Industry

Pharmaceutical Preparations

Website

nervgen.com/

Headquarters

Vancouver, British Columbia, Can

Founded

Nervgen Pharma Corporation is listed in the Pharmaceutical Preparations sector of the TSX Venture Exchange with ticker NGEN. The last closing price for Nervgen Pharma was $2.86. Over the last year, Nervgen Pharma shares have traded in a share price range of $ 0.00 to $ 0.00.

Nervgen Pharma currently has 59,606,000 shares outstanding. The market capitalization of Nervgen Pharma is $170.47 million. Nervgen Pharma has a price to earnings ratio (PE ratio) of -7.62.

L'Organisme canadien de réglementation des investissements permet la reprise de la négociation - NGEN

L'Organisme canadien de réglementation des investissements permet la reprise de la négociation - NGEN Canada NewsWire VANCOUVER, BC, le 21 mars 2024 VANCOUVER, BC, le 21 mars 2024...

Canadian Investment Regulatory Organization Trade Resumption - NGEN

Canadian Investment Regulatory Organization Trade Resumption - NGEN Canada NewsWire VANCOUVER, BC, March 21, 2024 VANCOUVER, BC, March 21, 2024 /CNW/ - Trading resumes in: Company: NervGen...

NERVGEN ANNOUNCES $20 MILLION BOUGHT DEAL OFFERING

NERVGEN ANNOUNCES $20 MILLION BOUGHT DEAL OFFERING Canada NewsWire VANCOUVER, BC, March 21, 2024 /NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED...

Suspension de la négociation par l'Organisme canadien de réglementation des investissements - NGEN

Suspension de la négociation par l'Organisme canadien de réglementation des investissements - NGEN Canada NewsWire VANCOUVER, BC, le 21 mars 2024 VANCOUVER, BC, le 21 mars 2024...

Canadian Investment Regulatory Organization Trading Halt - NGEN

Canadian Investment Regulatory Organization Trading Halt - NGEN Canada NewsWire VANCOUVER, BC, March 21, 2024 VANCOUVER, BC, March 21, 2024 /CNW/ - The following issues have been halted by...

Take Part in the Next Generation of Spinal Cord Injury Treatments with These Companies

For anyone with a spinal cord injury (SCI), time is of the essence. The typical treatment scenario involves immobilization and surgery as quickly as possible. After that, managing To read the full...

Small Company Working on Big Breakthrough in Treating Spinal Cord Injuries

Spinal cord injuries (SCI) can be devastating, and they can lead to a loss of mobility, sensation, and independence. There is no cure for SCI, and the treatments that are To read the full story on...

Life Science Investor Forum Agenda Announced for June 22nd

NEW YORK, June 20, 2023 (GLOBE NEWSWIRE) -- Virtual Investor Conferences, the leading proprietary investor conference series, today announced the agenda for the Life Science Investor Forum...

NervGen Pharma’s NVG-291-R Demonstrates Significant Functional Repair From a Stroke 7 Days After Onset in Landmark Preclinical Study by University of Cincinnati and Case Western Reserve University

The independent peer-reviewed study showed improved memory as well as motor and sensory functions in rodents when treatment with NVG-291-R began 7 days after stroke onset There is currently no...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	0	0	0	0	0	0	0	CS
4	0	0	0	0	0	0	0	CS
12	0	0	0	0	0	0	0	CS
26	0	0	0	0	0	0	0	CS
52	0	0	0	0	0	0	0	CS
156	0	0	0	0	0	0	0	CS
260	0	0	0	0	0	0	0	CS

NGEN - Frequently Asked Questions (FAQ)

What is the current Nervgen Pharma share price?

The current share price of Nervgen Pharma is $ 2.86

How many Nervgen Pharma shares are in issue?

Nervgen Pharma has 59,606,000 shares in issue

What is the market cap of Nervgen Pharma?

The market capitalisation of Nervgen Pharma is CAD 170.47M

What is the 1 year trading range for Nervgen Pharma share price?

Nervgen Pharma has traded in the range of $ 0.00 to $ 0.00 during the past year

What is the PE ratio of Nervgen Pharma?

The price to earnings ratio of Nervgen Pharma is -7.62

What is the reporting currency for Nervgen Pharma?

Nervgen Pharma reports financial results in CAD

What is the latest annual profit for Nervgen Pharma?

The latest annual profit of Nervgen Pharma is CAD -22.38M

What is the registered address of Nervgen Pharma?

The registered address for Nervgen Pharma is 1133 MELVILLE STREET, SUITE 3500, THE STACK, VANCOUVER, BRITISH COLUMBIA, V6E 4E5

What is the Nervgen Pharma website address?

The website address for Nervgen Pharma is nervgen.com/

Which industry sector does Nervgen Pharma operate in?

Nervgen Pharma operates in the PHARMACEUTICAL PREPARATIONS sector

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
ADG.HArcus Development Group Inc	$ 0.025 (400.00%)	260.5k
CEN.HClaren Energy Corp	$ 0.155 (342.86%)	25k
SGUSignature Resources Ltd	$ 0.06 (100.00%)	1.2M
BOCABocana Resources Corp	$ 0.01 (100.00%)	64k
CPICarlton Precious Inc	$ 0.09 (80.00%)	34.5k
RGIReco International Group Inc	$ 0.01 (-50.00%)	28k
CNST.PConstellation Capital Corp	$ 0.04 (-42.86%)	20k
GAR.HGreen Arrow Resources Inc	$ 0.025 (-37.50%)	2k
CBLUClear Blue Technologies International Inc	$ 0.02 (-33.33%)	11k
MTLOMartello Technologies Group Inc	$ 0.01 (-33.33%)	4.74k
LUCALuca Mining Corp	$ 1.02 (5.15%)	7.95M
OMIOrosur Mining Inc	$ 0.245 (44.12%)	2.57M
AGAGArgenta Silver Corp	$ 0.26 (6.12%)	2.32M
SXLSlam Exploration Ltd	$ 0.025 (25.00%)	1.88M
CHSComprehensive Healthcare Systems Inc	$ 0.01 (0.00%)	1.87M